clarithromycin has been researched along with Pleurisy in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukao, A; Horikawa, S; Ikeue, T; Noguchi, S; Ohi, I; Sugita, T; Tanaka, E; Terashita, S; Yoshida, H | 1 |
Delia, S; Iona, E; Mascellino, MT; Mastroianni, CM; Ponzo, R | 1 |
Carnuccio, R; D'Acquisto, F; Di Rosa, M; Ialenti, A; Ianaro, A; Iuvone, T; Maffia, P; RombolĂ , L; Sautebin, L | 1 |
3 other study(ies) available for clarithromycin and Pleurisy
Article | Year |
---|---|
Pleuritis Caused by Mycobacterium kyorinense without Pulmonary Involvement.
Topics: Clarithromycin; Cough; Dyspnea; Exudates and Transudates; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Mycobacterium Infections; Pleurisy; Tomography, X-Ray Computed | 2017 |
Infections due to Rhodococcus equi in three HIV-infected patients: microbiological findings and antibiotic susceptibility.
Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Azithromycin; Bacteremia; Bronchoalveolar Lavage Fluid; Clarithromycin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; HIV Infections; Humans; Imipenem; Male; Pleurisy; Pneumonia, Bacterial; Rhodococcus equi; Rifampin; Sputum; Teicoplanin; Vancomycin | 1994 |
Anti-inflammatory activity of macrolide antibiotics.
Topics: 6-Ketoprostaglandin F1 alpha; Adrenalectomy; Anesthesia; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Azithromycin; Carrageenan; Cell Line; Clarithromycin; Cyclooxygenase 2; Cytokines; Dinoprostone; Dose-Response Relationship, Drug; Erythromycin; Inflammation Mediators; Isoenzymes; Leukotriene B4; Macrophages; Mice; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Pleurisy; Prostaglandin-Endoperoxide Synthases; Rats; Roxithromycin; Time Factors; Tumor Necrosis Factor-alpha | 2000 |